Nopal (Prickly Pear Cactus) for Blood Sugar

Nopal is the flat green pad of the prickly pear cactus (Opuntia), eaten as a vegetable in Mexico and used there in traditional medicine for diabetes. In small, single-day tests in people with type 2 diabetes, a meal of broiled or steamed pads lowered blood glucose over the following hours. Raw preparations did not lower blood glucose, and a dried extract did not lower fasting glucose. None of the studies read for this page ran long enough to measure hemoglobin A1C (HbA1c), the blood test that reflects average glucose over about three months, and the reviews describe the evidence as promising but not yet sufficient.

Evidence base: six small human test-meal studies, none of them indexed in PubMed as a randomized controlled trial; four reviews of human studies; and animal and laboratory work. The human evidence is thin, and that is itself one of the findings on this page.


Table of Contents

  1. What Nopal Is and How It Has Been Used
  2. Active Compounds and How They Act
  3. What Human Trials Found
  4. Why Species and Preparation Matter
  5. What the Reviews Concluded
  6. What Animal and Laboratory Studies Found
  7. Amounts Used in the Trials
  8. Safety Findings and Interactions
  9. Limits of the Evidence
  10. Key Research Papers
  11. Connections
  12. Featured Videos

What Nopal Is and How It Has Been Used

Prickly pear cacti belong to the plant group Opuntia. The plant grows as a chain of flat, oval, fleshy segments. Botanists call each segment a cladode, which means a flattened stem; the research papers call them cladodes, stems or pads. In Mexico the pads are called nopal, and they are cooked and eaten as a vegetable. The sweet fruit of the same plant is the prickly pear, also called cactus pear. This page is about the pad, not the fruit.

A 2014 clinical trial report describes nopal as a plant used in traditional Mexican medicine to treat diabetes (PMID 25132122). A 2011 report on Opuntia streptacantha describes the traditional preparation: the pad is liquefied, and the plant is also taken as “agua de uso”, a cold infusion drunk over the course of a day (PMID 21111796).

A 2008 review lists nopal among nine botanicals that are frequently promoted to help manage blood glucose, alongside bitter melon, fenugreek, gymnema, ivy gourd, ginseng, aloe vera, Russian tarragon and garlic (PMID 18537692). What that review concluded about all nine is reported below.

Back to Table of Contents

Active Compounds and How They Act

No single compound has been shown to be responsible for nopal's effect on blood glucose in people. The studies point to several possible explanations, and one common explanation was tested in the laboratory and not confirmed. A 2019 systematic review of the human studies states that the mechanisms “require further elucidation” (PMID 31096667).

Fibre and thickness

A 2022 narrative review states that the pad's high fibre content may be involved, by affecting glucose absorption and slowing the release of glucose into the blood (PMID 35208623). A laboratory and rat study of dried Opuntia ficus-indica pads fits that idea. Flours made from small and medium pads had more dietary fibre and made thicker (more viscous) mixtures with water than flour from large pads. In a laboratory test of how fast glucose spreads through the mixture, the same two flours stood out, while the large-pad flour behaved almost like the control (PMID 24164385).

Insulin fell together with glucose

Insulin is the hormone that moves glucose out of the blood and into cells. In a 1988 study of patients with type 2 diabetes, blood insulin did not rise after a meal of broiled nopal. It fell: by 50.2 ± 8.0% in one group and 40.3 ± 12.4% in another, three hours after eating. The authors wrote that the mechanism is unknown and suggested that the body may be responding better to its own insulin (increased insulin sensitivity) (PMID 3276479). In the 2014 trial, the insulin response to a high-carbohydrate breakfast was also lower when steamed nopal was eaten with it (PMID 25132122).

Gut hormones

Glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide 1 (GLP-1) are hormones the gut releases after a meal; both signal the pancreas to release insulin. The 2014 trial measured them. In seven healthy people, dehydrated nopal produced a GIP index of 6.5 ± 3.0 and a GLP-1 index of 25.9 ± 18, each calculated against the same amount of carbohydrate eaten as pure glucose. In patients with type 2 diabetes, adding steamed nopal to one of the two test breakfasts significantly reduced the peaks of GIP at 30 and 45 minutes (PMID 25132122).

Not by blocking starch-digesting enzymes (animal and laboratory finding)

Alpha-glucosidases are enzymes in the gut wall that split starch and double sugars into glucose. The diabetes drug acarbose works by blocking them. A 2012 study tested whether Opuntia streptacantha works the same way. In animals, a total extract (100 mg/kg) and the plant's juice (4 mL/kg) did hold down the rise in blood glucose after a dose of maltose, a double sugar. But in a laboratory enzyme test the extracts did not block alpha-glucosidases, and in a test on a piece of small intestine they had neither an enzyme effect nor a physical barrier effect on the breakdown of double sugars. The authors concluded that the glucose effect of this species is not due to action on these enzymes (PMID 22155472).

Compounds named in animal and laboratory work

Three kinds of compound are named in the animal and laboratory studies: isorhamnetin glycosides, plant polyphenols that Opuntia ficus-indica is rich in (PMID 25588195); polysaccharides, long chains of sugar units described as one of the main components of Opuntia (PMID 37054824); and a (4-hydroxy)-phenyl acetic acid derivative newly identified in Opuntia streptacantha extracts (PMID 21111796). None of them was given to people as an isolated substance in the studies read for this page. What each did in animals is in the animal and laboratory section.

Back to Table of Contents

What Human Trials Found

Every human study below is a short test on a single day. People ate nopal once, and their blood was sampled over the next few hours, six hours at most. The groups were small, from 6 to 16 patients. The comparison was water, empty capsules, or the same breakfast without nopal. None of the six studies is indexed in PubMed as a randomized controlled trial, and the abstracts do not describe random assignment or blinding. Glucose values are given in milligrams per decilitre (mg/dl), as the abstracts give them. P is the probability that a difference of that size arose by chance; a value below 0.05 is the usual threshold for calling a result statistically significant.

Broiled pads of Opuntia streptacantha in type 2 diabetes

The 1988 study. Three groups of patients with non-insulin-dependent diabetes mellitus, the older name for type 2 diabetes, were tested. Sixteen patients ate 500 g of broiled nopal stems. Ten patients drank 400 ml of water as a control. Six more patients did three tests each: nopal, water, and 500 g of broiled squash. Blood glucose and insulin were measured for 180 minutes. After nopal, both fell significantly; after water in the control group, they did not. At 180 minutes glucose had fallen by 17.6 ± 2.2% of its starting value in the group of sixteen and by 16.2 ± 1.8% in the group of six. The abstract does not give the result of the squash test (PMID 3276479).

More nopal, larger fall. In a 1989 study, eight patients with type 2 diabetes each did four tests: 400 ml of water, and 100 g, 300 g and 500 g of broiled stems. The largest fall in blood glucose came at 180 minutes. The mean fall from the starting value was 2.3 mg/dl with water (not statistically significant), 10 mg/dl with 100 g (P < 0.05), 30.1 mg/dl with 300 g (P < 0.001) and 46.7 mg/dl with 500 g (P < 0.001). The amount eaten and the size of the fall were significantly correlated (r = 0.690, P < 0.001) (PMID 2557805).

Mean fall in blood glucose 180 minutes after water or 100, 300 and 500 grams of broiled Opuntia streptacantha pads in eight patients with type 2 diabetes: 2.3, 10, 30.1 and 46.7 mg/dl Fall in blood glucose 3 hours after the test meal 8 patients with type 2 diabetes, each tested 4 times 400 ml of water (control) 2.3 mg/dl (not significant) 100 g broiled pads 10 mg/dl 300 g broiled pads 30.1 mg/dl 500 g broiled pads 46.7 mg/dl Opuntia streptacantha, single test meals. Source: PMID 2557805

One study, eight patients, one day per test. The chart shows that study's numbers and nothing more.

How long the fall lasted. Eight patients with type 2 diabetes were tested while fasting, once with 500 g of broiled stems and once with 400 ml of water, and their blood glucose was measured every hour for six hours. After nopal, the fall was most pronounced at the fourth hour (P < 0.01 against the water test) and glucose stayed unchanged for the following two hours. Glucose did not change significantly in the water test. The difference between the two tests was significant from the second hour to the sixth (PMID 2488768).

Raw preparations of the same species: no effect

Eight patients with type 2 diabetes each did five tests. Three used raw material from 500 g of Opuntia streptacantha stem: the clear liquid, the solid sediment, and the complete blended pad. The fourth was 400 ml of water and the fifth was 500 g of broiled stems. None of the three raw preparations caused a significant fall in blood glucose; the results were similar to water (P > 0.05). The broiled stems, in the same patients, lowered blood glucose to 48.3 ± 16.2 mg/dl below the starting value at 180 minutes (P < 0.01). The authors wrote that heating may be necessary to obtain the effect (PMID 2488772).

A dried extract of Opuntia ficus-indica: no fall in fasting glucose

A 1989 study asked whether a dehydrated extract of nopal stems keeps the effect of the whole stems. Six patients with type 2 diabetes, fasting, took 30 capsules containing 10.1 ± 0.3 g of the extract, and blood glucose was measured hourly for 180 minutes. Empty capsules served as the control. The extract did not reduce fasting glucose in the patients with diabetes.

In a second experiment, six healthy volunteers took the same 30 capsules and then drank 74 g of dextrose (glucose). Their peak blood glucose was 20.3 ± 18.2 mg/dl lower with the extract than with empty capsules (P < 0.025). The authors concluded that the dried extract showed no acute glucose-lowering effect, although it could blunt the rise in glucose after a sugar load (PMID 2561256).

Steamed pads of Opuntia ficus-indica with breakfast

The most recent human study in the set, published in 2014 and indexed as a controlled clinical trial, had two parts (PMID 25132122).

In the first part, seven healthy people ate 50 g of available carbohydrate either as glucose or as dehydrated nopal. The glycemic index of nopal, a score of how much a food raises blood glucose compared with pure glucose, was 32.5 ± 4. Its insulinemic index, the same kind of score for insulin, was 36.1 ± 6.

In the second part, 14 patients with type 2 diabetes ate a high-carbohydrate breakfast or a breakfast high in soy protein, each with or without 300 g of steamed nopal. After the high-carbohydrate breakfast with nopal, the total glucose exposure over the test (the area under the glucose curve) was significantly lower than after the same breakfast alone: 287 ± 30 against 443 ± 49. The insulin response was lower too: 5,952 ± 833 against 7,313 ± 1,090. The abstract gives no units for these figures. With the other breakfast, nopal significantly reduced the peaks of the gut hormone GIP at 30 and 45 minutes and raised a laboratory measure of antioxidant activity after 2 hours.

The six human studies side by side

Single-day test-meal studies of nopal pads. None measured hemoglobin A1C.
What was eaten Who was tested Result for blood glucose Source
500 g broiled pads, Opuntia streptacantha 16 patients and 6 patients with type 2 diabetes; 10 patients given water Fell 17.6 ± 2.2% and 16.2 ± 1.8% from the starting value at 180 minutes; no similar change with water PMID 3276479
100 g, 300 g and 500 g broiled pads, Opuntia streptacantha 8 patients with type 2 diabetes Fell 10, 30.1 and 46.7 mg/dl at 180 minutes; 2.3 mg/dl with water (not significant) PMID 2557805
500 g broiled pads, Opuntia streptacantha, followed for six hours 8 patients with type 2 diabetes, fasting Lower than the water test from the second hour to the sixth; largest fall at the fourth hour PMID 2488768
Raw liquid, raw sediment or whole raw blend from 500 g of pads, Opuntia streptacantha 8 patients with type 2 diabetes No significant fall; similar to water. Broiled pads in the same patients: 48.3 ± 16.2 mg/dl lower at 180 minutes PMID 2488772
30 capsules of dehydrated extract (10.1 ± 0.3 g), Opuntia ficus-indica 6 patients with type 2 diabetes, fasting; 6 healthy volunteers given 74 g of dextrose No fall in fasting glucose in the patients. In the healthy volunteers, peak glucose after dextrose was 20.3 ± 18.2 mg/dl lower PMID 2561256
300 g steamed pads with breakfast, Opuntia ficus-indica 14 patients with type 2 diabetes Area under the glucose curve 287 ± 30 with nopal against 443 ± 49 without, after a high-carbohydrate breakfast PMID 25132122

Back to Table of Contents

Why Species and Preparation Matter

“Nopal” is not one thing in the research. The result depended on which cactus was used, which part of it, and what was done to it before it was eaten.

Back to Table of Contents

What the Reviews Concluded

A systematic review searches the published studies by a fixed method and reports all that meet its rules. A meta-analysis goes one step further and combines their numbers. A narrative review is an expert summary without a fixed search method.

2008 review of nine botanicals

This review covered nine plants promoted for blood glucose, including nopal (Opuntia streptacantha), with the emphasis on studies in people. It found a “paucity of data” on efficacy and safety in humans. Its conclusion: because of the lack of sufficient evidence from clinical studies for any of the nine, it is premature to actively recommend any particular herb to treat glucose, and well defined randomized clinical trials are warranted (PMID 18537692).

2019 systematic review of prickly pear and blood glucose

The reviewers searched six databases, found 335 articles, and kept 20 human studies: 12 of the pad, 4 of the fruit and 4 of other Opuntia products. Pad studies and some of the other products mostly showed significant reductions in blood glucose and insulin. Fruit studies mostly showed no significant effect.

The review also judged the quality of the studies. Those that used the pad alone or the fruit alone had a high risk of bias, meaning their design left room for the result to be distorted. Studies of combined products had a lower risk of bias. The reviewers concluded that there is a lack of evidence to support using prickly pear fruit products as an alternative or complementary therapy for type 2 diabetes, and that the pad “does however show promise” in glucose-lowering effects that warrant further investigation (PMID 31096667).

2022 narrative review of the pads

This brief review reports that several studies found lower blood glucose after meals when pads or pad products were eaten, and it describes the pad as a potential food ingredient for glycemic control. It also states the gap plainly: there is a lack of evidence on the chronic (long-term) effects of the pad, and research on long-term glycemic control is warranted (PMID 35208623).

2023 meta-analysis of four Mexican foods in people with obesity

This systematic review and meta-analysis pooled 15 studies with 1,670 participants (843 in the intervention groups and 827 in the control groups). It combined four foods in one analysis: cocoa, nopal, avocado and common bean. The participants had obesity; the review was not limited to people with diabetes.

Body mass index fell significantly: a mean difference of −0.80 (95% confidence interval −1.31 to −0.30, p = 0.002), with very high variation between studies (heterogeneity I2 = 92%). For fasting glucose the mean difference was −0.81, with a range from −5.81 to 4.19. For insulin it was −0.15, with a range from −0.80 to 0.50. Both ranges run from below zero to above zero, so the pooled results for fasting glucose and insulin are compatible with no change. The abstract gives no units for these figures.

The authors wrote that these foods seem to improve body measurements, blood fats and glycemic control in obesity, and that more randomized controlled trials are needed for decisive evidence on amount and method of use. Because the four foods were pooled, the result cannot be read as a finding about nopal by itself (PMID 36981103).

Back to Table of Contents

What Animal and Laboratory Studies Found

Everything in this section comes from rats, mice, isolated cells or laboratory tests. These studies help explain how nopal might act. They do not show what it does in people.

Opuntia streptacantha extracts in diabetic rats

Rats were made diabetic with streptozotocin, a chemical used in research to damage the insulin-producing cells. Two extracts of the pad were tested: the traditional liquefied extract (135 mg/kg) and a further filtered version of it (27 mg/kg). Given by themselves, the extracts did not significantly lower blood glucose compared with the control group. Given before an oral glucose tolerance test, in which the animal receives a dose of glucose, the same extracts held down the rise in blood glucose (liquefied extract 135 mg/kg; filtered extract 12 and 27 mg/kg) (PMID 21111796).

A 2012 animal and laboratory study of the same species, described above, confirmed the effect after a dose of maltose and found that enzyme blocking did not explain it (PMID 22155472).

Opuntia ficus-indica pad flour in diabetic rats

Pads at three stages of maturity, from the same crop and location, were dried and ground. In streptozotocin-diabetic rats given 50 mg/kg of body weight, flour from medium pads reduced blood glucose after feeding by 46.0% and flour from small pads by 23.6%, compared with the control (p < 0.05). Flour from large pads had no significant effect (PMID 24164385).

An isorhamnetin glycoside extract in mice on a high-fat diet

An Opuntia ficus-indica extract was added to a high-fat diet at 0.3% or 0.6% and fed to mice for 12 weeks. Compared with mice on the high-fat diet alone, the mice that received the extract gained less body weight, had lower blood glucose and insulin, and had lower total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol. The extract improved glucose tolerance and raised energy expenditure. Their insulin still tended to be higher than in control mice. In isolated pancreatic islets, the clusters of cells that make insulin, the extract stimulated insulin release in the laboratory dish (PMID 25588195).

Pooled animal studies of Opuntia polysaccharide

A 2023 systematic review and meta-analysis pooled 16 studies of Opuntia polysaccharide in animal models of diabetes. Compared with untreated diabetic animals, the polysaccharide significantly improved blood glucose, body weight, food intake, water intake, total cholesterol, triglycerides, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol. The dose, the animal species, the length of treatment and the way diabetes was induced were possible sources of the differences between studies. The mechanisms the reviewers proposed are immune regulation, repair of damaged insulin-producing beta cells, and reduced oxidative stress and cell death. All of this is in animals (PMID 37054824).

A third species: Opuntia humifusa in rats

A 2023 systematic review and meta-analysis of Opuntia humifusa, a different prickly pear species, included 15 studies across several uses. For diabetes its evidence was in diabetic rats, where treatment lowered glucose and triglyceride levels and raised high-density lipoprotein cholesterol (PMID 36671035).

Back to Table of Contents

Amounts Used in the Trials

These are the amounts the researchers gave in single test meals. They are a record of what was studied, not amounts for a reader to take.

Every one of these was a single test. None of the studies read for this page reports an amount eaten daily for weeks or months, and the 2023 meta-analysis states that more randomized controlled trials are needed for decisive evidence about dosage and method of supplementation (PMID 36981103). The animal amounts in the section above (milligrams per kilogram of body weight, or a percentage of the diet) are research doses for rats and mice and are not amounts for people.

Back to Table of Contents

Safety Findings and Interactions

Back to Table of Contents

Limits of the Evidence

In short: a meal of cooked nopal pads lowered blood glucose for a few hours in small groups of people with type 2 diabetes. Whether eating nopal regularly changes long-term glucose control has not been tested in the studies read for this page.

Back to Table of Contents

Key Research Papers

  1. Frati-Munari AC, Gordillo BE, Altamirano P, Ariza CR. Hypoglycemic effect of Opuntia streptacantha Lemaire in NIDDM. Diabetes Care. 1988;11(1):63-6. PubMed PMID: 3276479
  2. Frati-Munari AC, Del Valle-Martínez LM, Ariza-Andraca CR, Islas-Andrade S, Chávez-Negrete A. [Hypoglycemic action of different doses of nopal (Opuntia streptacantha Lemaire) in patients with type II diabetes mellitus]. Arch Invest Med (Mex). 1989;20(2):197-201. PubMed PMID: 2557805
  3. Frati-Munari AC, Ríos Gil U, Ariza-Andraca CR, Islas Andrade S, López Ledesma R. [Duration of the hypoglycemic action of Opuntia streptacantha Lem]. Arch Invest Med (Mex). 1989;20(4):297-300. PubMed PMID: 2488768
  4. Frati-Munari AC, Altamirano-Bustamante E, Rodríguez-Bárcenas N, Ariza-Andraca R, López-Ledesma R. [Hypoglycemic action of Opuntia streptacantha Lemaire: study using raw extracts]. Arch Invest Med (Mex). 1989;20(4):321-5. PubMed PMID: 2488772
  5. Frati-Munari AC, de León C, Ariza-Andraca R, Bañales-Ham MB, López-Ledesma R, Lozoya X. [Effect of a dehydrated extract of nopal (Opuntia ficus indica Mill.) on blood glucose]. Arch Invest Med (Mex). 1989;20(3):211-6. PubMed PMID: 2561256
  6. López-Romero P, Pichardo-Ontiveros E, Avila-Nava A, Vázquez-Manjarrez N, Tovar AR, Pedraza-Chaverri J, et al. The effect of nopal (Opuntia ficus indica) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts. J Acad Nutr Diet. 2014;114(11):1811-8. PubMed PMID: 25132122
  7. Cefalu WT, Ye J, Wang ZQ. Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr Metab Immune Disord Drug Targets. 2008;8(2):78-81. PubMed PMID: 18537692
  8. Gouws CA, Georgousopoulou EN, Mellor DD, McKune A, Naumovski N. Effects of the Consumption of Prickly Pear Cacti (Opuntia spp.) and its Products on Blood Glucose Levels and Insulin: A Systematic Review. Medicina (Kaunas). 2019;55(5):138. PubMed PMID: 31096667
  9. Kashif RR, D'Cunha NM, Mellor DD, Alexopoulos NI, Sergi D, Naumovski N. Prickly Pear Cacti (Opuntia spp.) Cladodes as a Functional Ingredient for Hyperglycemia Management: A Brief Narrative Review. Medicina (Kaunas). 2022;58(2):300. PubMed PMID: 35208623
  10. Escutia-Gutiérrez R, Sandoval-Rodríguez A, Galicia-Moreno M, Rosas-Campos R, Almeida-López M, Santos A, et al. Mexican Ancestral Foods (Theobroma cacao, Opuntia ficus indica, Persea americana and Phaseolus vulgaris) Supplementation on Anthropometric, Lipid and Glycemic Control Variables in Obese Patients: A Systematic Review and Meta-Analysis. Foods. 2023;12(6):1177. PubMed PMID: 36981103
  11. Andrade-Cetto A, Wiedenfeld H. Anti-hyperglycemic effect of Opuntia streptacantha Lem. J Ethnopharmacol. 2011;133(2):940-3. PubMed PMID: 21111796
  12. Becerra-Jiménez J, Andrade-Cetto A. Effect of Opuntia streptacantha Lem. on alpha-glucosidase activity. J Ethnopharmacol. 2012;139(2):493-6. PubMed PMID: 22155472
  13. Nuñez-López MA, Paredes-López O, Reynoso-Camacho R. Functional and hypoglycemic properties of nopal cladodes (O. ficus-indica) at different maturity stages using in vitro and in vivo tests. J Agric Food Chem. 2013;61(46):10981-6. PubMed PMID: 24164385
  14. Rodríguez-Rodríguez C, Torres N, Gutiérrez-Uribe JA, Noriega LG, Torre-Villalvazo I, Leal-Díaz AM, et al. The effect of isorhamnetin glycosides extracted from Opuntia ficus-indica in a mouse model of diet induced obesity. Food Funct. 2015;6(3):805-15. PubMed PMID: 25588195
  15. Chen R, Ma K, Li S, Zhou X, Chen H. Protective effects and mechanisms of opuntia polysaccharide in animal models of diabetes mellitus: A systematic review and meta-analysis. J Ethnopharmacol. 2023;312:116490. PubMed PMID: 37054824
  16. Ngoc LTN, Moon JY, Lee YC. Beneficial Effects of Opuntia humifusa (Korean Cheonnyuncho) on Human Health Based on Antioxidant Properties: Systematic Review and Meta-Analysis. Antioxidants (Basel). 2023;12(1):174. PubMed PMID: 36671035

PubMed Topic Searches

  1. PubMed: Opuntia and type 2 diabetes, randomized studies
  2. PubMed: Nopal and blood glucose after meals
  3. PubMed: Opuntia streptacantha and blood glucose
  4. PubMed: Prickly pear pads and glycemic response
  5. PubMed: Opuntia, glucose and insulin, systematic reviews

Back to Table of Contents

Connections

Back to Table of Contents